PD-1 inhibitor peptide (Aurigene)
N/A
Report date: 2026/05/23 20:00:57
Base Information
Drug NamePD-1 inhibitor peptide (Aurigene)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAurigene Oncology Ltd
China Registration ClassN/A
Develop Information
Active CompaniesSun Yat-Sen University
Inactive CompaniesAurigene Oncology Ltd
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A